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A bismuth diethyldithiocarbamate compound promotes apoptosis in HepG2 carcinoma, 
cell cycle arrest and inhibits cell invasion through modulation of the NF-κB activation 
pathway 
ABSTRACT 
The compound with R = CH2CH3 in Bi(S2CNR2)3 (1) is highly cytotoxic against a range of 
human carcinoma, whereas that with R = CH2CH2OH (2) is considerably less so. Both 1 and 
2 induce apoptosis in HepG2 cells with some evidence for necrosis induced by 2. Based on 
DNA fragmentation, caspase activities and human apoptosis PCR-array analysis, both the 
extrinsic and intrinsic pathways of apoptosis have been shown to occur. While both 
compounds activate mitochondrial and FAS apoptotic pathways, compound 1 was also found 
to induce another death receptor-dependent pathway by induction of CD40, CD40L and 
TNF-R1 (p55). Further, 1 highly expressed DAPK1, a tumour suppressor, with concomitant 
down-regulation of XIAP and NF-κB. Cell cycle arrest at the S and G2/M phases correlates 
with the inhibition of the growth of HepG2 cells. The cell invasion rate of 2 is 10-fold higher 
than that of 1, a finding correlated with the down-regulation of survivin and XIAP expression 
by 1. Compounds 1 and 2 interact with DNA through different binding motifs with 1 
interacting with AT- or TA-specific sites followed by inhibition of restriction enzyme 
digestion; 2 did not interfere with any of the studied restriction enzymes. 
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